Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/30/2007US20070202172 Metoprolol succinate E.R. tablets and methods for their preparation
08/30/2007US20070202171 Method Of Producing A Pharmaceutical Composition
08/30/2007US20070202170 Dual-release compositions of a cyclooxygenase-2 inhibitor
08/30/2007US20070202169 Lansoprazole orally disintegrating tablets
08/30/2007US20070202168 Composition comprises sustained-release fine particles and manufacturing method thereof
08/30/2007US20070202167 Hyoscyamine dosage form
08/30/2007US20070202163 Fast-disintegrating epinephrine tablets for buccal or sublingual administration
08/30/2007US20070202162 Extended release pharmaceutical compositions
08/30/2007US20070202160 Solid-state form of celecoxib having enhanced bioavailability
08/30/2007US20070202158 Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation
08/30/2007US20070202157 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome
08/30/2007US20070202155 Low dose no donor-containing transdermal patch
08/30/2007US20070202153 Liquid Concentrated Formula
08/30/2007US20070202150 Implantable device formed from polymer and plasticizer blends
08/30/2007US20070202147 Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
08/30/2007US20070202146 Implantable device formed from polymer and plasticizer blends having modified molecular structures
08/30/2007US20070202145 Method for incorporation of bioactives into a porous hydrophobic polymer scaffold
08/30/2007US20070202138 Antimicrobial compositions and method
08/30/2007US20070202134 Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis
08/30/2007US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
08/30/2007US20070202128 Immunomodulatory oligonucleotides
08/30/2007US20070202126 biodegradable; improved anthropogenic carbon dioxide emission profile
08/30/2007US20070202120 Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use
08/30/2007US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/30/2007US20070202114 Higher gene expression in sample indicates tumor is tamoxifen-resistant; drug screening
08/30/2007US20070202104 Treatment of spondyloarthropathies using TNFalpha inhibitors
08/30/2007US20070202101 Combination therapy using anti-EGFR antibodies and anti-hormonal agents
08/30/2007US20070202092 Use of beta-1,3 (4)-endoglucanohydrolase beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
08/30/2007US20070202091 Nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans
08/30/2007US20070202090 Water Soluble Form Of Coenzyme Q10 In The Form Of An Inclusion Complex With Beta-Cyclodextrin, Process Of Preparing, And Use Thereof
08/30/2007US20070202084 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
08/30/2007US20070202079 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/30/2007US20070202078 Method Of Treating Viral Infections
08/30/2007US20070202077 Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders
08/30/2007US20070202076 Methods and compositions for the targeted delivery of therapeutics
08/30/2007US20070202074 Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
08/30/2007US20070202060 Retinoid-Containing Preparations
08/30/2007US20070202058 Compositions for treating gastric reflux
08/30/2007US20070202057 Disintegrable oral films
08/30/2007US20070202055 Pharmaceutical Formulations
08/30/2007US20070202054 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
08/30/2007US20070202053 Pharmaceutical Formulations For Dry Powder Inhalers Comprising A Low-Dosage Strength Active Ingredient
08/30/2007US20070202052 Method for increasing the expression of pulmonary surfactant protein-B
08/30/2007US20070202051 Aerosols for sinunasal drug delivery
08/30/2007US20070202050 Pharmaceutical Formulations
08/30/2007US20070202046 Implantable device formed from polymer blends
08/30/2007US20070202044 Antibody therapy
08/30/2007DE212007000001U1 Kombinationspräparat zur Verbesserung der Samenqualität Combination product for improving sperm quality
08/30/2007DE102007016516A1 Arzneimittelzubereitung The pharmaceutical preparation
08/30/2007DE102006008773A1 Wirkstoffkombination aus Hydroxymatairesinol, Phenoxyethanol und gewünschtenfalls Glycerin Combination of active substances hydroxymatairesinol, phenoxyethanol and, if desired, glycerol
08/30/2007DE102006007830A1 Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure A storage-stable oral dosage form of amoxicillin and clavulanic acid
08/30/2007DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
08/30/2007CA2664982A1 Cleavable carnitine compound
08/30/2007CA2655614A1 Treatment of cancer with 2-deoxygalactose
08/30/2007CA2645414A1 Method for screening hiv drug sensitivity
08/30/2007CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007CA2643731A1 Inhibitors of pai-1 for treatment of muscular conditions
08/30/2007CA2643688A1 Co-crystals and pharmaceutical compositions comprising the same
08/30/2007CA2643668A1 Salt of cd 80 antagonist
08/30/2007CA2643665A1 Indolopyridines as eg5 kinesin modulators
08/30/2007CA2643562A1 2-(phenyl or heterocyclic)-1h-phenanthro[9,10-d]imidazoles
08/30/2007CA2643561A1 Cancerous disease modifying antibody 141205-05
08/30/2007CA2643488A1 Indolopyridines as eg5 kinesin modulators
08/30/2007CA2643299A1 Compositions to reduce blood glucose levels and treat diabetes
08/30/2007CA2643277A1 Methods and compositions for bactericide, bacteriostatic and anti-inflammation
08/30/2007CA2643274A1 Oil-in-water emulsion composition containing licorice-derived polyphenol
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2643270A1 Pharmaceutical composition and functional food for suppressing and relieving itching and inflammation
08/30/2007CA2643228A1 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
08/30/2007CA2643130A1 Compounds and methods of treating disorders associated with activation of metachromatic cells
08/30/2007CA2643063A1 Cancerous disease modifying antibody 141205-02
08/30/2007CA2643056A1 Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
08/30/2007CA2643031A1 Methods and compositions for treating hyperalgesia
08/30/2007CA2643028A1 Substituted taraxastanes useful for treating viral infections
08/30/2007CA2643012A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
08/30/2007CA2642988A1 Pharmaceutical product comprising a benzimidazole in combination with a desiccant
08/30/2007CA2642952A1 Pharmaceutical composition comprising oseltamivir phosphate
08/30/2007CA2642933A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
08/30/2007CA2642921A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors
08/30/2007CA2642843A1 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome
08/30/2007CA2642834A1 Oxa-steroids derivatives as selective progesterone receptor modulators
08/30/2007CA2642832A1 Pyrazolylquinazolinones as potassium channel openers
08/30/2007CA2642829A1 11-phosphorous steroid derivatives useful as progesterone receptor modulators
08/30/2007CA2642794A1 Hydantoin based kinase inhibitors
08/30/2007CA2642778A1 The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
08/30/2007CA2642763A1 Tetracyclic steroid derivatives useful as progesterone receptor modulators
08/30/2007CA2642762A1 Pyrrolidine derivatives as erk inhibitors
08/30/2007CA2642737A1 Oxazole ketones as modulators of fatty acid amide hydrolase
08/30/2007CA2642726A1 Stable vitamin c compositions
08/30/2007CA2642717A1 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
08/30/2007CA2642687A1 Crystal form of besipirdine chlorhydrate, process preparation and use thereof
08/30/2007CA2642685A1 Antihypertensive therapy
08/30/2007CA2642672A1 Methods and compositions for the treatment of parkinson's disease
08/30/2007CA2642650A1 Novel heterocyclic diphenyl ethers
08/30/2007CA2642630A1 Piperazine derivatives
08/30/2007CA2642619A1 Pyrrole derivative or salt thereof
08/30/2007CA2642610A1 Amide derivative or salt thereof
08/30/2007CA2642566A1 17-phosphorous steroid derivatives useful as progesterone receptor modulators
08/30/2007CA2642487A1 Novel application of topical anesthetics for modulation of neurogenic tremor
08/30/2007CA2642340A1 Metoprolol succinate e.r. tablets and methods for their preparation
1 ... 3605 3606 3607 3608 3609 3610 3611 3612 3613 3614 3615 3616 3617 3618 3619 3620 3621 3622 3623 3624 3625 ... 7860